NEUROGENE
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 12 Apr 2024)
What this means for you
Registered since 16 Oct 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87777749
- Registration number
- 5588158
- Mark type
- Stylized text
- Filed
- 31 Jan 2018
- Published for opposition
- 19 Jun 2018
- Registered
- 16 Oct 2018
- Attorney of record
- Perry J. Viscounty
Goods and services
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields
Owner
- NEUROGENE INC., NEW YORK, NY, US
- McMinn, Rachel L, New York, NY, US
- McMinn, Rachel L, New York, NY, US
- McMinn, Rachel L, New York, NY, US
Prosecution history
- 12 Apr 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 12 Apr 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 12 Apr 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Oct 2023 — TEAS SECTION 8 & 15 RECEIVED
- 16 Oct 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Dec 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 04 Dec 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 04 Dec 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 Dec 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 04 Dec 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 Dec 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 16 Oct 2018 — REGISTERED-PRINCIPAL REGISTER
- 14 Sept 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Sept 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Sept 2018 — STATEMENT OF USE PROCESSING COMPLETE